The Lancet. Global health
-
The Lancet. Global health · Apr 2020
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults.
Stroke is a leading cause of death and disability worldwide. Despite considerable improvements in diagnosis and treatment, little is known about the short-term and long-term prognosis after a first stroke in low-income and middle-income countries, including China. We aimed to assess the short-term and long-term risk of recurrent stroke and mortality after a first stroke for each of the major pathological stroke types. ⋯ © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
-
The Lancet. Global health · Feb 2020
Randomized Controlled TrialCause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
The Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) trial found that biannual mass distribution of azithromycin to children younger than 5 years in Niger reduced the primary outcome of all-cause mortality by 18%. We aimed to determine the causes of mortality among deceased children using verbal autopsy. ⋯ Bill & Melinda Gates Foundation.
-
The Lancet. Global health · Feb 2020
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
Infectious pathogens are strong and modifiable causes of cancer. The aim of this study was to improve estimates of the global and regional burden of infection-attributable cancers to inform research priorities and facilitate prevention efforts. ⋯ International Agency for Research on Cancer.